InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,443.60
(
2.15%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
-1.03%
)
Bitcoin
63,000.00
(
6.56%
)
Post# of 15662
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

JohnnyD3

Send PM Follow Ignore
Followers 3
Posts 383
Boards Moderated 0
Alias Born 08/25/2012

JohnnyD3

Re: None

Thursday, 10/30/2014 11:33:05 PM

Thursday, October 30, 2014 11:33:05 PM

Post# of 15662
Ebola Clinical Trials: Big Name Players

http://www.biospace.com/News/ebola-clinical-trials-big-name-players-in-the/350579

in Philadelphia, Hemispherx Biopharma (HEB) focuses on treating and preventing chronic viral and immune-based disorders. The company's flagship products include Alferon N Injection and an experimental immunotherapeutic dubbed Ampligen. On September 29, 2014, the company announced widening its research collaborations to develop therapeutic cocktails against Ebola virus.

Ampligen and Alferon are presently in the lab testing phase in eight labs in the U.S., Western Europe, and Canada. It is in the discussion phase in West Africa with various government officials.


Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent HEB News
More HEB News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!